Rifamycin (Cosmo Pharma)

N/A

Report date: 2024/07/31 16:12:03

Base Information

Drug NameRifamycin (Cosmo Pharma)
Drug Alias NameRifamycin 1% enemaCB-01-35
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionBacterial DNA-directed RNA polymerase inhibitors
TargetsBacterial DNA-directed RNA polymerase
Therapy Area/IndicationsUlcerative proctitisColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIreland
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCosmo Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesCosmo Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsUlcerative proctitisColitis, Ulcerative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A